The Characteristics, Treatment Patterns and Prognosis of Chinese Male Breast Cancer: A Real-world Study
NCT ID: NCT06220630
Last Updated: 2024-01-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1200 participants
OBSERVATIONAL
2021-08-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* The characteristics, treatment patterns and prognosis of Chinese MBC patients. The clinicopathological characteristics, treatment information and follow-up data of participants will be extracted from a Chinese national database (Chinese Society of Clinical Oncology Breast Cancer database) and other involved Chinese centers.
Researchers will investigate the features, survival associated factors and other relevant factors of this population.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiac Substructure Radiation Dose and Early Clinical Monitoring of Stage N2-3 Non-Small Cell Lung Cancer
NCT05252065
Development of a Scale for Cancer Patients' Willingness to Voluntarily Participate in Drug Clinical Trials
NCT06120335
Study on the Accuracy of Proteomics in Evaluating Lymph Node Metastasis Status in Cholangiocarcinoma Patients
NCT05721963
A Study of the Gene Mutation Status in Cerebrospinal Fluid, Blood and Tumor Tissue of Non-small Cell Lung Cancer Patients With Brain Metastases
NCT03257735
Prospective Screening Programme for Malignant Tumors
NCT04230200
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* The characteristics, treatment patterns and prognosis of Chinese MBC patients. The clinicopathological characteristics, treatment information and follow-up data of participants will be extracted from a Chinese national database (Chinese Society of Clinical Oncology Breast Cancer database) and other involved Chinese centers.
Researchers will investigate the features, survival associated factors and other relevant factors of this population.
The collected variables included: survival time, survival status, year of diagnosis, age, stage, molecular subtype statuses, histology, grade, and surgery, radiotherapy and systemic therapies utilization.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chinese
About 1,200 Chinese male breast cancer cases are anticipated to collected retrospectively. The clinicopathological characteristics, treatment and survival information are retrospectively collected.
Breast cancer
Male patients who were microscopically diagnosed as primary breast cancer.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Breast cancer
Male patients who were microscopically diagnosed as primary breast cancer.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Microscopically diagnosed as primary breast cancer.
Exclusion Criteria
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Medical Award Foundation
UNKNOWN
The Affiliated Cancer Hospital of Xinjiang Medical University
UNKNOWN
Hebei Medical University Fourth Hospital
OTHER
The Third Affiliated Hospital of Kunming Medical University
UNKNOWN
Sun Yat-sen University
OTHER
The Affiliated Cancer Hospital of Zhengzhou University
UNKNOWN
The Third Hospital of Nanchang City
UNKNOWN
Beijing 302 Hospital
OTHER
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
OTHER
Fujian Provincial Hospital
OTHER
First Hospital of China Medical University
OTHER
The Affiliated Hospital of Qingdao University
OTHER
Guangdong Provincial People's Hospital
OTHER
First Affiliated Hospital Xi'an Jiaotong University
OTHER
First People's Hospital of Foshan
OTHER
Peking University First Hospital
OTHER
The Affiliated Hospital Of Guizhou Medical University
OTHER
Guangdong Provincial Hospital of Traditional Chinese Medicine
OTHER
Jiangmen Central Hospital
OTHER
The Second Affiliated Hospital, Guangzhou Medical University
UNKNOWN
The First Affiliated Hospital, Zhejiang University
UNKNOWN
Peking University Shenzhen Hospital
OTHER
The Second Affiliated Hospital of Harbin Medical University
OTHER
Affiliated Sanming First Hospital of Fujian Medical University
UNKNOWN
Jieyang People's Hospital
OTHER
National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital
UNKNOWN
Shantou Central Hospital
OTHER
The First Affiliated Hospital with Nanjing Medical University
OTHER
Lianjiang Pepole's Hospital, Lianjiang
UNKNOWN
Guangdong Women and Children Hospital
OTHER
Zhanjiang Central Hospital
UNKNOWN
Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine
UNKNOWN
First Affiliated Hospital, Sun Yat-Sen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ying Lin
MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ying Lin, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
1st affiliated hospital of Sun Yat-sen university
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
First affiliated hospital of Sun Yat-sen university
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021[516]
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.